The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

ConditionsOMI - Occlusion Myocardial Infarction Artificial Intelligence (AI)Electrocardiogram Cost-effectiveness Analysis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorNational Defense Medical Center, Taiwan

About this trial

This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.

Eligibility criteria

Qualifiers

Patients in the emergency department

Patients received at least 1 ECG examination.

Disqualifiers

The patients received ECG at the period of inactive AI-ECG system.

Patients with a history of coronary angiography within the past 3 days.

Trial design

Treatments tested in this trial

AI-ECG P4P program

Treatment groups

212,000 Participants

are divided into 2 treatment groups

Locations

Kaohsiung Armed Forces General Hospital807, Kaohsiung CityTaiwan, Taiwan

Taipei Municipal Wanfang Hospital114, Taipei Taiwan

Tri-Service General Hospital114, Taipei Taiwan

Sponsors and collaborators

National Defense Medical Center, Taiwan

Lead sponsor

Source ClinicalTrials.gov